# InMed Pharmaceuticals Inc.: Form 8-K, filed Jun 30, 2025

- Company: [InMed Pharmaceuticals Inc.](/companies/inm.md) (CIK 1728328)
- Form: 8-K
- Filed: 2025-06-30
- Accepted by EDGAR: Jun 30, 2025, 16:16 ET
- Period: 2025-06-24
- Accession: 0001213900-25-059673
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1728328/000121390025059673/ea0247476-8k_inmed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1728328/000121390025059673/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1728328/000121390025059673/ea0247476-8k_inmed.htm

Filed Jun 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-059673. Last ingested by Listed: Oct 29, 2026, 04:34 ET. No prices; not investment advice.